AR005868A1 - Compuesto derivado de azo- y diazocicloheptano y -cicloctano sustituido, composición farmacologica que lo contiene y uso del mismo - Google Patents
Compuesto derivado de azo- y diazocicloheptano y -cicloctano sustituido, composición farmacologica que lo contiene y uso del mismoInfo
- Publication number
- AR005868A1 AR005868A1 ARP970100120A ARP970100120A AR005868A1 AR 005868 A1 AR005868 A1 AR 005868A1 AR P970100120 A ARP970100120 A AR P970100120A AR P970100120 A ARP970100120 A AR P970100120A AR 005868 A1 AR005868 A1 AR 005868A1
- Authority
- AR
- Argentina
- Prior art keywords
- ring
- substituted
- alkyl
- radical
- alkylene group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
Abstract
Compuestos azo- y diazocicloheptano y -cicloctano que poseen la fórmula (I) : Ar1-A-B-Ar2, donde Ar1 es (II) o (III) o un anillo heteroaromático de 5 o6 miembros con 1, 2 o 3 heteroátomos que se seleccionan, independientemente entre sí de O, N,y S; donde Ar1 puede tener 1, 2, 3 o 4 sustituyentes que seseleccionan independientemente entre si, de OR1, un alquilo sustituido o no, o un alquenilo de C2-C6, un alquinilo de C2-C6, un cicloalquilo, entre otros,donde R1 es H, un alquilosustituido o no, por OH, OC1-C6-alquilo, fenilo o un halógeno; A es un grupo alquileno de C3-C15 cuando Ar1 es C6H5CONH o biencuando Ar1 es un anillo heteroatómico de 5 o 6 miembros es un grupo alquileno de C4-C15 o un grupo alquileno deC3-C15; B es un anillo saturado de 7 u 8miembros con uno o dos heteroátomos de nitrógeno los que se ubican en la posición 1,4 o 1,5 y el anillo está unido en la posición 1 al radical A y enla posición 4 o 5 al radical Ar2, y además es posibleque el anillo po sea un doble enlace en la posición 3 o 4 en el anillo monoazo y en la posición 6 enel anillo 1,4-diazo; Ar2 es un fenilo, piridilo, piridinilo o triazinilo, siendo posible que Ar2 tenga 1, 2, 3 o 4 sustituyentes que seseleccionan,independie ntemente entre sí, de OR, un alquilo, un alquenilo de C2-C6, un alquinilo de C2-C6, alcoxialquilo, haloalquilo, halógeno, entre otros y Ar1también se puede fusionar con un anillo carbocíclico, y donde Ar2 no puedeser un radical pirimidini lo sustituido por 2 grupos hidroxilo; así como lassales de los mismos formados con ácidos tolerables fisiológicamente, que poseen una alta afinidad por el receptor de dopamina D3 y por lo tanto puedenemplearse paratratar los trastornos que re sponden a lo ligandos del receptor de dopamina D3, mediante el uso de una composición farmacéutica que lo contiene
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19600934A DE19600934A1 (de) | 1996-01-12 | 1996-01-12 | Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR005868A1 true AR005868A1 (es) | 1999-07-21 |
Family
ID=7782613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970100120A AR005868A1 (es) | 1996-01-12 | 1997-01-13 | Compuesto derivado de azo- y diazocicloheptano y -cicloctano sustituido, composición farmacologica que lo contiene y uso del mismo |
Country Status (26)
Country | Link |
---|---|
US (2) | US6214822B1 (es) |
EP (1) | EP0877744B1 (es) |
JP (1) | JP4349657B2 (es) |
KR (1) | KR100441073B1 (es) |
CN (2) | CN1075070C (es) |
AR (1) | AR005868A1 (es) |
AT (1) | ATE273301T1 (es) |
AU (1) | AU717726B2 (es) |
BG (1) | BG64098B1 (es) |
CA (1) | CA2241787C (es) |
CO (1) | CO4790173A1 (es) |
CZ (1) | CZ297981B6 (es) |
DE (2) | DE19600934A1 (es) |
ES (1) | ES2225947T3 (es) |
HR (1) | HRP970021A2 (es) |
HU (1) | HU228457B1 (es) |
IL (1) | IL125076A (es) |
MX (1) | MX9805499A (es) |
NO (1) | NO316753B1 (es) |
NZ (1) | NZ326332A (es) |
PL (1) | PL327692A1 (es) |
SK (1) | SK284987B6 (es) |
TR (1) | TR199801302T2 (es) |
TW (1) | TW475929B (es) |
WO (1) | WO1997025324A1 (es) |
ZA (1) | ZA97209B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19728996A1 (de) * | 1997-07-07 | 1999-01-14 | Basf Ag | Triazolverbindungen und deren Verwendung |
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
EA200100428A1 (ru) | 1998-10-08 | 2001-10-22 | Смитклайн Бичам Плс | Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты) |
AR022229A1 (es) * | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion |
DE19922443A1 (de) * | 1999-05-07 | 2000-11-09 | Basf Ag | Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen |
US7037916B2 (en) | 1999-07-15 | 2006-05-02 | Pharmacopeia Drug Discovery, Inc. | Pyrimidine derivatives as IL-8 receptor antagonists |
US20030087917A1 (en) * | 2000-03-27 | 2003-05-08 | Dorothea Strack | Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system |
EP1632483B1 (en) | 2001-02-16 | 2008-10-29 | Aventis Pharmaceuticals Inc. | Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
DE10109866A1 (de) * | 2001-03-01 | 2002-09-05 | Abbott Gmbh & Co Kg | Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie |
DE10131543A1 (de) * | 2001-06-29 | 2003-01-16 | Abbott Lab | Pyrimidinoxyalkylpiperazine und ihre therapeutische Verwendung |
US20050154039A1 (en) * | 2001-11-28 | 2005-07-14 | Marie-Odile Glacera Contour | 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
CN1642422A (zh) * | 2002-03-15 | 2005-07-20 | 西巴特殊化学品控股有限公司 | 4-氨基嘧啶及其在表面抗菌处理中的应用 |
DE10304870A1 (de) * | 2003-02-06 | 2004-08-19 | Abbott Gmbh & Co. Kg | Triazolverbindungen und ihre therapeutische Verwendung |
TW200507841A (en) * | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
DE10358004A1 (de) * | 2003-12-11 | 2005-07-14 | Abbott Gmbh & Co. Kg | Ketolactam-Verbindungen und ihre Verwendung |
DE102004027358A1 (de) | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyrimidinverbindungen und ihre Verwendung |
FR2877005A1 (fr) * | 2004-10-22 | 2006-04-28 | Bioprojet Soc Civ Ile | Nouveaux derives d'arylpiperazine |
US7511035B2 (en) * | 2005-01-25 | 2009-03-31 | Glaxo Group Limited | Antibacterial agents |
JP2007106746A (ja) * | 2005-09-13 | 2007-04-26 | Tosoh Corp | 新規アリールホモピペラジン類、またはその塩と製造方法 |
US7935706B2 (en) * | 2006-02-23 | 2011-05-03 | Shionogi & Co., Ltd. | Nitrogen-containing heterocycle derivatives substituted with cyclic group |
US20070293548A1 (en) * | 2006-03-31 | 2007-12-20 | Wang Eric Y | Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases |
EP1882688A1 (en) | 2006-07-25 | 2008-01-30 | EPFL Ecole Polytechnique Fédérale de Lausanne | Labelling of fusion proteins with synthetic probes |
JP4840440B2 (ja) * | 2008-12-24 | 2011-12-21 | ソニー株式会社 | 画像処理装置およびその方法、並びにプログラム |
GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
BR112012018500A2 (pt) * | 2010-01-25 | 2016-08-16 | Chdi Foundation Inc | alguns inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso destas |
US9156822B2 (en) * | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
CA2817165A1 (en) | 2010-11-15 | 2012-05-24 | Patrick Chaltin | Novel antiviral compounds |
SG2014011654A (en) | 2011-08-30 | 2014-08-28 | Chdi Foundation Inc | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
HUE034802T2 (en) | 2011-08-30 | 2018-02-28 | Chdi Foundation Inc | Kinurenin-3-monooxygenase inhibitors, pharmaceutical preparations and methods of use |
PT3087051T (pt) | 2013-12-24 | 2020-10-21 | Oncotartis Inc | Compostos de nicotinamida e benzamida e métodos para utilizar os mesmos |
KR20170026633A (ko) | 2014-07-17 | 2017-03-08 | 씨에이치디아이 파운데이션, 인코포레이티드 | Hiv-관련 장애의 치료 방법 및 치료용 조성물 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE628766A (es) | 1962-12-26 | |||
BE792206A (es) | 1971-12-02 | 1973-06-01 | Byk Gulden Lomberg Chem Fab | |
US5139998A (en) | 1988-08-31 | 1992-08-18 | Superconductor Technologies, Inc. | Controlled thallous oxide evaporation for thallium superconductor films and reactor design |
SE8803429D0 (sv) * | 1988-09-28 | 1988-09-28 | Pharmacia Ab | Novel pyridyl- and pyrimidyl derivatives |
US5008267A (en) | 1988-10-29 | 1991-04-16 | Mitsui Toatsu Chemicals, Incorporated | Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same |
JP2815218B2 (ja) | 1990-04-13 | 1998-10-27 | 三井化学株式会社 | ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤 |
FR2663638B2 (fr) | 1990-04-06 | 1995-02-10 | Institut Nal Sante Recherc Medic | Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides. |
JP2518965B2 (ja) | 1990-09-21 | 1996-07-31 | 三井東圧化学株式会社 | 新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤 |
FR2668771B1 (fr) | 1990-11-06 | 1995-03-17 | Inst Nat Sante Rech Med | Acides nucleiques codant pour des polypeptides ayant une activite de recepteur dopaminergique humain et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides. |
DE4425143A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
DE4425146A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
DE4425145A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung von Thiazol- und Thiadiazolverbindungen |
DE4425144A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Triazolverbindungen und deren Verwendung |
US5635503A (en) * | 1995-06-07 | 1997-06-03 | Bristol-Myers Squibb Company | Dihydropyridine npy antagonists: piperazine derivatives |
FR2742149B1 (fr) | 1995-12-11 | 1998-02-13 | Inst Nat Sante Rech Med | Nouveaux derives de 2-naphtamides et leurs applications therapeutiques |
-
1996
- 1996-01-12 DE DE19600934A patent/DE19600934A1/de not_active Withdrawn
-
1997
- 1997-01-10 SK SK941-98A patent/SK284987B6/sk not_active IP Right Cessation
- 1997-01-10 HU HU9901590A patent/HU228457B1/hu unknown
- 1997-01-10 JP JP52486997A patent/JP4349657B2/ja not_active Expired - Lifetime
- 1997-01-10 CA CA002241787A patent/CA2241787C/en not_active Expired - Lifetime
- 1997-01-10 KR KR10-1998-0705263A patent/KR100441073B1/ko not_active IP Right Cessation
- 1997-01-10 HR HRP19600934.0A patent/HRP970021A2/hr not_active Application Discontinuation
- 1997-01-10 CN CN97192755A patent/CN1075070C/zh not_active Expired - Lifetime
- 1997-01-10 CO CO97000912A patent/CO4790173A1/es unknown
- 1997-01-10 PL PL97327692A patent/PL327692A1/xx unknown
- 1997-01-10 US US09/101,265 patent/US6214822B1/en not_active Expired - Lifetime
- 1997-01-10 NZ NZ326332A patent/NZ326332A/en not_active IP Right Cessation
- 1997-01-10 ES ES97901000T patent/ES2225947T3/es not_active Expired - Lifetime
- 1997-01-10 WO PCT/EP1997/000106 patent/WO1997025324A1/de active IP Right Grant
- 1997-01-10 ZA ZA97209A patent/ZA97209B/xx unknown
- 1997-01-10 EP EP97901000A patent/EP0877744B1/de not_active Expired - Lifetime
- 1997-01-10 AT AT97901000T patent/ATE273301T1/de not_active IP Right Cessation
- 1997-01-10 TR TR1998/01302T patent/TR199801302T2/xx unknown
- 1997-01-10 DE DE59711847T patent/DE59711847D1/de not_active Expired - Lifetime
- 1997-01-10 AU AU14407/97A patent/AU717726B2/en not_active Expired
- 1997-01-10 CZ CZ0215998A patent/CZ297981B6/cs not_active IP Right Cessation
- 1997-01-10 IL IL12507697A patent/IL125076A/en not_active IP Right Cessation
- 1997-01-13 AR ARP970100120A patent/AR005868A1/es not_active Application Discontinuation
- 1997-01-13 TW TW086100296A patent/TW475929B/zh not_active IP Right Cessation
-
1998
- 1998-07-07 MX MX9805499A patent/MX9805499A/es unknown
- 1998-07-09 BG BG102616A patent/BG64098B1/bg unknown
- 1998-07-10 NO NO19983187A patent/NO316753B1/no not_active IP Right Cessation
-
2000
- 2000-10-27 US US09/696,941 patent/US6352981B1/en not_active Expired - Lifetime
-
2001
- 2001-04-20 CN CNB011170697A patent/CN1146551C/zh not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR005868A1 (es) | Compuesto derivado de azo- y diazocicloheptano y -cicloctano sustituido, composición farmacologica que lo contiene y uso del mismo | |
ES2162235T3 (es) | Piridazinaminas inhibidoras de la angiogenesis. | |
NO952151L (no) | Injiserbare, taxanderivat-baserte preparater | |
IT1311923B1 (it) | Composti farmaceutici. | |
ES2100187T3 (es) | Derivados de carboestirilos y composiciones farmaceuticas que los contienen. | |
AR245494A1 (es) | Una composicion detergente. | |
KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
DK0421561T3 (da) | 24-homo-vitamin-D-derivater, fremgangsmåder til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel | |
WO1998009953A3 (de) | Azinyloxy- und phenoxy-diaryl-carbonsäure derivate, deren herstellung und deren verwendung als gemischte eta/etb endothelin-rezeptorantagonist | |
DK157550C (da) | Analogifremgangsmaade til fremstilling af 8-aminoalkyl-xantinderivater. | |
SE8600174D0 (sv) | Nytt forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner | |
ES2009785B3 (es) | Procedimiento para preparar derivados de tioxantona. | |
SE8006498L (sv) | Karbostyrilderivat samt forfarande for framstellning av dem | |
TR199801218T2 (xx) | Takikinin antagonistleri olarak N-asil-2-ikameli-4-(Benzimidazolil-ya da imidazopiridinil-ikameli art�klar)-piperidinler. | |
PT77231B (en) | Process for the preparation of 2-nitro-1,1-ethenediamines having a hypotensive effect and their use for the preparation of pharmaceutical compositions with a hypotensive effect | |
DK163579C (da) | Analogifremgangsmaade til fremstilling af carbacyklinderivater | |
AR016691A1 (es) | Derivados de cromano sustituido con sulfonamida, el uso del mismo para la manufactura de un medicamento, intermediarios para su preparacion, y unacomposicion farmaceutica que los comprende | |
ES2027550A6 (es) | Procedimiento para preparar derivados de glicerol. | |
FI912164A0 (fi) | Foerfarande foer framstaellning av hydrazoner. | |
AR009105A1 (es) | Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica | |
ES2138100T3 (es) | Procedimiento para la preparacion de 1,5-benzotiazepinas por ciclizacion de esteres aminicos. | |
ES2037758T3 (es) | Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion. | |
ES8801895A1 (es) | Procedimiento para la obtencion de benzamidas | |
SE8300289L (sv) | 3,3-dialkyl- och 3,3-alkylen-indolinderivat, sett att framstella dessa och farmaceutiska kompositioner innehallande desamma | |
NO890889D0 (no) | Sementsammensetning for oljekildeborehull inneholdende poly(vinylaminer) med hoey molekylvekt. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |